Our Mission Continues
Infectious diseases devastate families every day. In 2015, 1.8 million people died from tuberculosis; the Zika virus began its rapid spread across Latin America and into the U.S.; and two million Americans contracted resistant bacterial infections, including new strains of drug-resistant superbugs. Together we’re responding to urgent state and federal calls for innovations combating infectious disease by creating an end-to-end vaccine research and development pipeline and accelerating new routes to eradicate pathogens.
Join The Team
Tuberculosis research has been a focus of the Trudeau Institute since its inception more than 125 years ago. Dr. Edward Livingston Trudeau, the Institute’s founder, was the first American physician to isolate the bacterium responsible for the disease, and he established the first U.S. laboratory for TB research in 1884.
Trudeau Institute Contract Research Organization (TICRO Bioservices) is a full-service contract research organization providing high-quality research project execution to both academic scientists and the biopharmaceutical industry. For nearly 50 years, the Trudeau Institute has been a world-renowned research center with a focus towards understanding the immunological, biological and molecular basis of infectious diseases and immune disorders, particularly in the respiratory tract.